Follow
Majid Jaberi-Douraki
Title
Cited by
Cited by
Year
Bacterial endotoxin (lipopolysaccharide) binds to the surface of gold nanoparticles, interferes with biocorona formation and induces human monocyte inflammatory activation
Y Li, Z Shi, I Radauer-Preiml, A Andosch, E Casals, U Luetz-Meindl, ...
Nanotoxicology, 19, 2018
972018
Biomimetic Natural Killer Membrane Camouflaged Polymeric Nanoparticle for Targeted Bioimaging
A Pitchaimani, TDT Nguyen, R Marasini, A Eliyapura, T Azizi, ...
Advanced Functional Materials, 2018
762018
Performance Assessment and Translation of Physiologically Based Pharmacokinetic Models from acslX to Berkeley Madonna, MATLAB, and R language: Oxytetracycline and Gold …
Z Lin, M Jaberi-Douraki, C He, S Jin, R Yang, J Fisher, J Riviere
Toxicol Sci, 2017
532017
Dynamics of a rational difference equation using both theoretical and computational approaches
M Dehghan, MJ Douraki, MJ Douraki
Applied Mathematics and Computation 168 (2), 756-775, 2005
422005
Study of a system of non-linear difference equations arising in a deterministic model for HIV infection
M Nasri, M Dehghan, MJ Douraki
Applied Mathematics and Computation 171 (2), 1306-1330, 2005
352005
Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of disease
M Jaberi‐Douraki, SW Liu, M Pietropaolo, A Khadra
Pediatric diabetes 15 (3), 162-174, 2014
302014
Optimal control of vaccination dynamics during an influenza epidemic
M Jaberi-Douraki, SM Moghadas
Mathematical Biosciences & Engineering 11 (5), 1045-1063, 2014
292014
PREDICTIVE MODELS OF TYPE 1 DIABETES PROGRESSION: UNDERSTANDING T-CELL CYCLES AND THEIR IMPLICATIONS ON AUTOANTIBODY RELEASE
M Jaberi-Douraki, M Pietropaolo, A Khadra
PloS one 9 (4), e93326, 2014
282014
Continuum model of T-cell avidity: understanding autoreactive and regulatory T-cell responses in type 1 diabetes
M Jaberi-Douraki, M Pietropaolo, A Khadra
Journal of theoretical biology 383, 93-105, 2015
272015
Unraveling the contribution of pancreatic beta-cell suicide in autoimmune type 1 diabetes
M Jaberi-Douraki, S Schnell, M Pietropaolo, A Khadra
Journal of theoretical biology 375, 77-87, 2015
262015
Comparative pharmacokinetics of oxytetracycline in tilapia (Oreochromis spp.) maintained at three different salinities
PK Sidhu, SA Smith, C Mayer, G Magnin, DD Kuhn, M Jaberi-Douraki, ...
Aquaculture 495, 675–681, 2018
252018
Serosurvey of human antibodies recognizing Aedes aegypti D7 salivary proteins in Colombia
BL Londono-Renteria, H Shakeri, P Rozo-Lopez, MJ Conway, ...
Frontiers in public health 6, 355246, 2018
252018
The qualitative behavior of solutions of a nonlinear difference equation
M Jaberi-Douraki, M Dehghan, M Razzaghi
Applied Mathematics and Computation 170 (1), 485-502, 2007
23*2007
Modeling gold nanoparticle biodistribution after arterial infusion into perfused tissue: Effects of surface coating, size and protein corona
JE Riviere, M Jaberi-Douraki, J Lillich, T Azizi, H Joo, K Choi, R Thakkar, ...
Nanotoxicology 12 (10), 1093-1112, 2018
212018
On the recursive sequence xn+ 1= α+ βxn-k+ 1+ γxn-2k+ 1Bxn-k+ 1+ Cxn-2k+ 1
M Dehghan, MJ Douraki
Applied mathematics and computation 170 (2), 1045-1066, 2005
21*2005
Mathematical modeling of the “inoculum effect”: six applicable models and the MIC advancement point concept
JR Salas, M Jaberi-Douraki, X Wen, VV Volkova
FEMS Microbiology Letters, 2020
202020
Making sense of pharmacovigilance and drug adverse event reporting: comparative similarity association analysis using AI machine learning algorithms in dogs and cats
X Xu, R Mazloom, A Goligerdian, J Staley, M Amini, GJ Wyckoff, J Riviere, ...
Topics in companion animal medicine 37, 100366, 2019
192019
Mathematical Modelling: A Graduate Textbook
SM Moghadas, M Jaberi-Douraki
Wiley, 2018
182018
Potential information loss due to categorization of Minimum Inhibitory Concentration frequency distributions
R Mazloom, M Jaberi-Douraki, JR Comer, V Volkova
Foodborne Pathogens and Disease 15 (1), 44-54, 2018
182018
Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID …
EG Stafford, JE Riviere, X Xu, J Kawakami, GJ Wyckoff, M Jaberi-Douraki
Journal of the American Pharmacists Association 60 (6), e145-e152, 2020
172020
The system can't perform the operation now. Try again later.
Articles 1–20